Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
SKINVISIBLE, INC. (SKVI)
Standardized SEC financial data for SKINVISIBLE, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001085277 · OTC · Pharmaceutical Preparations.
Revenue growth (YoY)
0.0%
Return on equity
10.4%
Free cash flow
-$42K
Current ratio
0.01×
EPS (diluted)
$-0.11
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
USD
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$153K
$663K
$279K
$20K
$20K
$20K
Cost of revenue
—
$3K
$5K
—
—
—
Gross profit
$276K
$660K
$274K
$20K
$20K
$20K
SG&A expense
$497K
$454K
Standardized from SKINVISIBLE, INC.'s SEC filings — per-share figures split-adjusted. Full history via the API.